Pauline Funchain, Medical Oncologist/Cancer Genomics at Cleveland Clinic, shared Neeraj Agarwal’s, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), post on X, adding:
“Increasingly oncology and other IM subspecialties are interconnected – a good problem to have now that our cancer drugs are better, our patients are living longer, and the goal is longevity from cancer AND longer term non-cancer issues.”
Quoting Neeraj Agarwal’s post:
“Out now in Journal of Clinical Oncology and Circulation: Our American Heart Association and American Society of Clinical Oncology joint scientific statement on defining cardiovascular (CV) endpoints in oncology trials. A framework for asking CV safety questions before trials begin.”
Neeraj Agarwal: AHA and ASCO Joint Statement on Defining Cardiovascular Endpoints in Oncology Trials
Other articles featuring Pauline Funchain and Neeraj Agarwal on OncoDaily.